SCHEDULE: SilverCape Proposes $4.00/Share Take-Private for PetMed Express

SilverCape Investments Limited has submitted a non-binding proposal to acquire all outstanding shares of PetMed Express Inc. for $4.00 per share in cash, aiming to take the company private.

Summary

• SilverCape Investments Limited and Peter Kennedy (Reporting Persons) have filed an Amendment No. 1 to their Schedule 13D.
• The Reporting Persons beneficially own 2,579,696 shares of PetMed Express Inc. Common Stock, representing approximately 12.28% of the outstanding shares.
• The shares were acquired through open market purchases for an aggregate price of $11,228,622, funded by SilverCape's working capital.
• SilverCape sent a non-binding proposal to PetMed Express Inc. on December 10, 2025, to acquire 100% of the outstanding Common Stock at $4.00 per share in cash.
• The proposed transaction, which would take the company private, would be funded by SilverCape's cash on hand and is not subject to financing conditions.
• The proposal is contingent on further due diligence (financial, legal, regulatory, etc.) and the execution of a mutually acceptable definitive agreement.
• The definitive agreement would also require the Issuer's board to render its shareholder rights plan or other anti-takeover protections inapplicable.
• SilverCape emphasizes the preliminary and non-binding nature of the proposal and reserves the right to modify or withdraw it at any time.
• The Reporting Persons intend to engage in discussions with the Issuer regarding the potential transaction.

Sentiment

Score: 7

Explanation: The sentiment is positive due to a concrete, non-binding take-private proposal at a premium, fully funded by cash on hand. However, the non-binding nature and contingencies introduce uncertainty, preventing a higher score.

Positives

• A non-binding proposal has been made to acquire 100% of PetMed Express Inc. at $4.00 per share in cash.
• The proposed acquisition price is stated to reflect a significant premium relative to the current market price of the company's common stock.
• The proposal is fully funded by SilverCape's cash on hand and is not subject to any financing conditions or contingencies, reducing execution risk related to funding.
• SilverCape believes the company would be best positioned as a private entity and is prepared to attribute significant value to the company's brand and licenses.

Negatives

• The proposal is preliminary and non-binding, meaning there is no guarantee a definitive agreement will be executed or that the transaction will be consummated.
• SilverCape reserves the right to modify or withdraw the proposal at any time without incurring liability.
• The proposal is subject to extensive due diligence, which could uncover issues leading to a withdrawal or renegotiation of terms.
• The Issuer's response and the timeline for any definitive agreement are uncertain.
• SilverCape requested strict confidentiality, and any leaks could lead to withdrawal of the proposal.

Risks

• Transaction Uncertainty: There is no assurance that a definitive agreement will be executed or that the potential transaction will be consummated.
• Due Diligence Risk: The proposal is subject to further due diligence, which could reveal information that leads SilverCape to modify or withdraw the offer.
• Regulatory and Anti-Takeover Protections: The transaction requires the Issuer's board to take actions to render its shareholder rights plan or other anti-takeover protections inapplicable.
• Market Price Volatility: The announcement of a non-binding proposal could lead to volatility in the Issuer's stock price, which may not reflect the ultimate outcome.
• Withdrawal Risk: SilverCape explicitly reserves the right to modify or withdraw the proposal at any time.

Future Outlook

SilverCape Investments Limited has proposed a non-binding transaction to take PetMed Express Inc. private at $4.00 per share. The Reporting Persons intend to engage in discussions with the Issuer, commence due diligence, and prepare a definitive agreement. They reserve the right to modify or withdraw the proposal and may take further steps to support their investment, including acquiring or disposing of shares, or formulating other plans based on ongoing evaluation of the company and market conditions.

Management Comments

• "We believe the Company would be best positioned as a private company, and we are prepared to attribute significant value to the Company's brand and licenses, and to work with the current leadership team to execute on a transaction to leverage these assets."
• "Our Proposal reflects a significant premium relative to the current market price of the Company's common stock, and we believe our Proposal also reflects the value of the Company's business and its long-term potential."
• "We believe the timing of the Potential Transaction is critical to preserving value for the Company's stockholders, and we look forward to commencing our due diligence and preparation of the Definitive Agreement as soon as possible."
• "SilverCape is excited to engage constructively with the Company, its management and board of directors, and its advisors to deliver a transaction that maximizes value for the Company's shareholders."

Industry Context

This proposal reflects a broader trend of private equity or investment firms seeking to acquire publicly traded companies, particularly those perceived as undervalued or better managed outside the public market's scrutiny. The pet care industry, in which PetMed Express operates, has seen consistent growth, making companies in this sector attractive targets for consolidation or strategic repositioning. Taking a company private can allow for long-term strategic changes without the pressure of quarterly earnings reports and public market expectations.

Corporate Governance

Stakeholder Impact

• Shareholders: Potential for a cash payout at a premium if the transaction is consummated, offering liquidity and a defined return. However, the non-binding nature introduces uncertainty and potential for share price volatility.
• Management/Employees: SilverCape expressed willingness to work with the current leadership team, but a take-private transaction could lead to organizational restructuring or changes in compensation/incentives.
• Board of Directors: The board will need to evaluate the proposal, potentially form a special committee, and consider its fiduciary duties to shareholders, including rendering anti-takeover protections inapplicable.

Next Steps

• Engage in discussions with PetMed Express Inc. regarding the potential transaction.
• Commence further due diligence (financial, tax, accounting, legal, compliance, human resources, IT, and regulatory).
• Prepare a mutually acceptable definitive agreement.
• The Issuer's board of directors would need to take actions to render its shareholder rights plan or other anti-takeover protections inapplicable.
• SilverCape may acquire additional securities or dispose of existing holdings, or formulate other plans based on ongoing evaluation.

Key Dates

Recommendation

While the non-binding proposal at a premium is positive, the inherent uncertainties of a non-binding offer, including due diligence risks, potential for withdrawal, and the need for a definitive agreement, suggest a "hold" recommendation. Investors should await further developments and a binding agreement before making definitive investment decisions, as the current offer is not guaranteed to close or close at the proposed terms. Selling now might forgo potential upside if the deal closes, while buying carries the risk of the deal falling through.

Keywords

PetMed Express, PMED, SilverCape Investments, Take-private, Acquisition proposal, Schedule 13D, Common Stock, Shareholder rights plan, Due diligence, Non-binding offer